Phase 3 Randomized Comparison of Concurrent Gemcitabine, Cisplatin, and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Cancer of the Cervix Stages IIB to IVA.

Trial Profile

Phase 3 Randomized Comparison of Concurrent Gemcitabine, Cisplatin, and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Cancer of the Cervix Stages IIB to IVA.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Mar 2011

At a glance

  • Drugs Cisplatin; Gemcitabine
  • Indications Cervical cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 28 Mar 2011 Additional location Panama reported in the Journal of Clinical Oncology.
    • 28 Mar 2011 Results published in the Journal of Clinical Oncology.
    • 24 Sep 2009 Results were presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology (ECCO-ESMO 2009).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top